Aparecida D. Oliveira
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Exploiting Paradoxical Activation of Oncogenic MAPK Signaling by Targeting Mitochondria to Sensitize NRAS Mutant-Melanoma to Vemurafenib.
Journal: International journal of molecular sciences
Published: February 18, 2025
TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors.
TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors.
Journal: Pharmacological research
Published: June 01, 2021
Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance.
Journal: Pharmacological research
Published: March 31, 2020
In vivo antitumoral effect of 4-nerolidylcatechol (4-NC) in NRAS-mutant human melanoma.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: December 17, 2019
ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC).
Journal: Pharmacological research
Published: December 09, 2018
Air Particulate Matter Induces Skin Barrier Dysfunction and Water Transport Alteration on a Reconstructed Human Epidermis Model.
Journal: The Journal of investigative dermatology
Published: December 01, 2018
Toxicogenomic and bioinformatics platforms to identify key molecular mechanisms of a curcumin-analogue DM-1 toxicity in melanoma cells.
Journal: Pharmacological research
Published: May 10, 2017
Functional investigation of bone implant viability using radiotracers in a new model of osteonecrosis.
Journal: Clinics (Sao Paulo, Brazil)
Published: May 13, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026